Innovative Eyewear, Inc. (LUCY) Stock

Innovative Eyewear, Inc. (LUCY) is a Healthcare stock trading at $0.85 (as of 2026-06-18), with a market capitalization of $5.15M and a trailing P/E of -0.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Innovative Eyewear, Inc. designs and sells connected eyeglasses and sunglasses, including Lucyd Lyte, which supports listening to music, phone calling, and hands-free use of voice assistants. The company also offers Vyrb for posting and social interaction through the glasses and distributes products via retail and e-commerce channels.

Valuation — source: SEC EDGAR (first-party)
Price	$0.85
Market Cap	$5.15M
P/E Ratio	-0.5
EV / EBITDA	-0.1
Price / Book	0.61
Price / Sales	1.72
DCF Value (model)	$-18.82
DCF Upside vs Price	-2313.9%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$2.66M
Net Margin	-285.2%
Return on Equity	-97.0%
Current Ratio	8.02
Revenue Growth (YoY)	62.6%
EPS Growth (YoY)	-63.4%
FCF Growth (YoY)	8.0%

Valuation vs Sector & Industry
Stock P/E	-0.5
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-102.5%
vs Industry	-101.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Cetera Investment Advisers ($545000.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Harrison Reed Gross
Employees	11
Country	US
IPO Date	2022-08-15

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.